Medicine & Health

Biomedical engineer Quing Zhu and WashU Medicine collaborators combined optical coherence tomography and machine learning for a rapid, accurate test for endometrial cancer.

A new study led by researchers at WashU Medicine suggests that younger generations are aging biologically faster than their older counterparts. This faster biological aging (represented by the right red clock) was also linked to early-onset cancers.

At the WashU Office of Technology Management’s annual Celebration of Inventors, WashU Medicine researchers Graham Colditz and Shu (Joy) Jiang were honored for developing and commercializing a technology to predict breast cancer risk.

Nicholas O. Davidson, MD, DSc, chief of the Division of Gastroenterology at WashU Medicine, has been honored with the 2026 Distinguished Mentor Award from the American Gastroenterological Association.

Nationally recognized physician-scientist Matthew A. Powell, MD, at WashU Medicine, will lead the effort to advance gynecologic cancer care.

Cancer cells are ravenous eaters. WashU’s Gary Patti is trying to turn their hunger against them.

A new study led by WashU Medicine researchers shows that, for blood cancer patients, a genetically engineered stem cell transplant helps prevent toxic side effects and potentially improves the effectiveness of therapies.

A WashU Medicine-led clinical trial has found that a personalized vaccine to treat glioblastoma appears to increase recurrence-free survival in a subset of patients after surgery.

Two WashU Medicine researchers have received three-year, $750,000 awards from the Edward P. Evans Foundation to advance the study of certain types of blood cancer.

WashU Medicine researchers have found in mice that two types of immune cells are involved in triggering strong cancer-killing T-cell responses with mRNA vaccines, offering new insights into designing cancer vaccines.